Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Christopher Mirabelli


  • Pres., Ceo & Chairman Of Board at Leap Therapeutics Inc. (LPTX), 2019-06-12
  • Other at Globeimmune Inc (GBIM), 2016-02-19
  • Large Shareholder, Director at Proteostasis Therapeutics Inc. (PTI), 2016-02-17
  • Large Shareholder, Director at Trevena Inc (TRVN), 2014-02-07
  • Large Shareholder at Tetralogic Pharmaceuticals Corp (TLOG), 2013-12-17
  • Large Shareholder at Radius Health Inc. (NONE), 2011-12-23
  • Large Shareholder at Pharmathene Inc (PIP), 2010-11-05
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LPTX $1.75 571,428 Large Shareholder, Officer, Director 4,114,804 2019-02-05 Filing
LPTX $6.09 1,057,769 Large Shareholder, Officer, Director 3,573,376 2017-11-14 Filing
PTI $8.00 375,000 Large Shareholder, Director 2,149,295 2016-02-17 Filing